Hydrolyzed Whey for Cholesterol Management in Adults
Standard whey
+ Hydrolyzed whey
Inflammation
+ Pathologic Processes
+ Pathological Conditions, Signs and Symptoms
Prevention Study
Summary
Study start date: August 5, 2025
Actual date on which the first participant was enrolled.This study explores the potential benefits of hydrolyzed whey protein for managing cholesterol levels in adults aged 21 to 59. Many people within this age group have borderline high cholesterol and do not use medication to manage it. The aim is to see if a specific type of whey protein can help lower cholesterol levels directly, which could be a safe and cost-effective alternative to medications. This research might also show if hydrolyzed whey can reduce low-level inflammation, which is linked to several long-term health problems. Participants will consume either hydrolyzed whey protein or whey protein isolate daily for six weeks. The study is designed to be double-blind, meaning neither the participants nor the researchers will know which protein each participant is consuming. Blood samples will be taken before and after the six-week period to measure changes in cholesterol levels and inflammation markers. The study aims to determine if there is a significant change in these health markers, with safety considerations primarily focusing on potential allergies to whey protein. Participants with known milk allergies will not be eligible to join.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.72 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 21 to 59 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
PlaceboGroup II
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location